---
title: 'Senior Director, Alliance Management at Kailera Therapeutics, Inc.'
canonical: 'https://feeny.ai/job/senior-director-alliance-management-kailera-therapeutics-inc-united-states-68myhez9bm6n'
type: 'job'
last_seen: '2026-11-07'
---

# Senior Director, Alliance Management at Kailera Therapeutics, Inc.

- **Company:** Kailera Therapeutics, Inc.
- **Location:** United States
- **Compensation:** $242k–$290k
- **Work type:** remote
- **Posted:** 2026-10-26
- **Last confirmed live:** 2026-11-07
- **Apply:** https://job-boards.greenhouse.io/kailera/jobs/5463452008

## Job description

At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.

We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.

What You’ll Do:

The Senior Director, Alliance Manager is responsible for building, managing, and nurturing strategic partnerships and alliances with external stakeholders. This role focuses on driving collaboration, maximizing the value of partnerships, and ensuring alignment between alliance goals and organizational objectives. The ideal candidate is a skilled relationship manager with experience in collaborating with multi-cultural partners, fostering trust, and delivering mutually beneficial outcomes.

Required location: Waltham, MA (hub-based, onsite 3-4 days per week) OR Remote (home-based, onsite at a hub 1 week every other month).

Responsibilities:

- Manage and strengthen Kailera's strategic alliance with Hengrui Pharmaceuticals, serving as the primary relationship lead and ensuring achievement of shared partnership objectives
- Serve as the primary point of contact for partners, ensuring ongoing communication, alignment of goals, and addressing any issues that arise
- Liaise with internal key subject matter experts and stakeholders across functions and within partner's organization to identify and resolve issues and gaps
- Co-lead with alliance partner to drive efficient and effective governance meetings
- Work with relevant functions to manage the development, execution, and ongoing compliance of partnership agreements, including contract negotiations and terms
- Provide regular updates to internal stakeholders on the progress and outcomes of partnerships, ensuring transparency and alignment on both sides
- Collaborate with colleagues in Business Development to support new initiatives to maximize the value of alliance

Required Qualifications:

- At least 12 years’ experience in the biotech/pharmaceutical industry with 5+ years’ experience in alliance management, with a track record of having successfully managed partnerships
- Strong interpersonal and communication skills, demonstrated creativity, flexibility and problem-solving ability, solid knowledge base regarding business development and alliance management practices
- Strong ability to manage cross-functional and multi-cultural teams and the ability to influence and collaborate effectively with internal and external stakeholders
- Experience in contract management and navigating complex legal agreements
- Strong project management skills with the ability to manage multiple programs simultaneously
- Lead, and develop a high-performing Alliance Management team, providing coaching, mentorship, and strategic direction
- Professional fluency in English and Mandarin (written and verbal) is required to effectively collaborate with Mandarin-speaking external partners and to review, interpret, and communicate information contained in Mandarin-language documents and communications

Education:

- Bachelor’s degree in business, life sciences or related field (advanced degree preferred)

Salary Range $242,000—$290,000 USD

For Full Time Roles: This range represents the company’s good-faith estimate of the salary at the time of posting. Actual pay may vary based on experience, skills, qualifications, location, and internal equity. We also offer comprehensive health coverage, flexible time off, paid holidays, and a year-end shutdown. Enjoy a monthly wellness stipend, generous 401(k) match, tuition reimbursement, commuter benefits, disability and life insurance, plus annual bonus opportunities and equity grants—because your well-being and future matter to us.

## EQUAL EMPLOYMENT OPPORTUNITY INFORMATION:

Kailera Therapeutics, Inc. is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race (including traits historically associated with race, such as hair texture and protective hairstyles), color, creed, religion (including religious dress and grooming practices), national origin, ancestry, citizenship status, age (40 and over), sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, reproductive health decisions, domestic victim status, political affiliation, or any other characteristic protected by applicable federal, state, or local laws and ordinances.

E-Verify:

Kailera Therapeutics, Inc. uses E-Verify to confirm the identity and employment eligibility of all new hires.

#LI-Hybrid

## About Kailera Therapeutics, Inc.

## Company Overview
- **One-liner**: Kailera Therapeutics is an advanced clinical-stage biotechnology company developing a diversified pipeline of GLP-1‑based therapies for obesity and overweight.
- **Entity Type**: Private (clinical stage; in‑licensed through a strategic collaboration with Jiangsu Hengrui Pharmaceuticals)
- **Headquarters**: Waltham, Massachusetts, United States
- **Founded**: Not publicly available
- **Founders**: Not publicly available

## Core Business
- **Primary industries**: Biotechnology / Obesity therapeutics
- **Target customers**: B2B (pharma partnerships) and ultimately patients and healthcare providers managing obesity and overweight
- **Mission**: To give people the power to restore their health and transform their lives by delivering category‑leading obesity management medications. [kailera.com/about-us](https://www.kailera.com/about-us/)

## Products & Services
Kailera’s pipeline is designed to address diverse unmet needs in obesity care, building on clinical data from Hengrui’s trials in China. All candidates are in‑licensed from Hengrui with exclusive rights outside China, Hong Kong, Macau and Taiwan.

- **Ribupatide (KAI‑9531)** – Once‑weekly injectable GLP‑1/GIP receptor dual agonist peptide; currently in a global Phase 3 program.
- **Ribupatide oral tablet** – Once‑daily oral formulation of the dual agonist.
- **KAI‑7535** – Oral small‑molecule GLP‑1 receptor agonist (clinical stage).
- **KAI‑4729** – Once‑weekly injectable GLP‑1/GIP/glucagon receptor tri‑agonist (clinical stage).

## Market Standing
- **Valuation / Market Cap**: Not disclosed (private company)
- **Key Metric**: Total funding – not publicly available; revenue – none (pre‑commercial). Pipeline lead in Phase 3.
- **Notable Investors / Partners**: Jiangsu Hengrui Pharmaceuticals Co., Ltd. (strategic collaboration and in‑licensing partner). Leadership team includes veterans from Cerevel Therapeutics, Translate Bio, Bain Capital Life Sciences, Amgen, Frazier Life Sciences, and AbbVie. [kailera.com/leadership](https://www.kailera.com/leadership/)
- **Growth Signals**:
  - Ribupatide clinical data presented at the American Diabetes Association (ADA) 2026.
  - Global Phase 3 program underway for ribupatide.
  - Multiple clinical‑stage candidates (oral, small molecule, tri‑agonist) targeting different patient needs.
  - Active hiring with 29 open positions (as of mid‑2026) across R&D, clinical, supply chain, regulatory, and corporate functions. [job-boards.greenhouse.io/kailera](http://job-boards.greenhouse.io/kailera)

## Competitive Advantages
- **Diversified modality pipeline**: Injectable dual agonist, oral formulation, oral small molecule, and tri‑agonist – covering a broad range of patient preferences and treatment stages.
- **Cross‑border development acceleration**: Access to Hengrui’s clinical data from China informs and de‑risks global trials.
- **World‑class leadership**: CEO Ron Renaud (former CEO of Cerevel and Translate Bio, both acquired by AbbVie and Sanofi respectively). CMO Scott Wasserman, M.D. (former CEO of Latigo Biotherapeutics, former Amgen VP leading metabolic and cardiovascular portfolios). Commercial and operational executives from top pharma. [kailera.com/leadership](https://www.kailera.com/leadership/)
- **Obesity‑first focus**: Pipeline deliberately built for the chronic, progressive nature of obesity, aiming to address the gap for greater weight loss and higher‑BMI patients.

## Strategic Focus
Kailera’s immediate priority is advancing ribupatide through Phase 3 to regulatory submission while progressing the earlier‑stage oral and tri‑agonist programs. The company aims to “elevate the next era of obesity care” by delivering multiple options for patients no matter where they are in their treatment journey. [kailera.com/](https://www.kailera.com/)

## Why Work Here
- **Culture (“Kai Values”)**: Emphasizes courage, collaboration, compassion, and commitment. The team operates with entrepreneurial spirit, transparency, and a patient‑centered mission. [kailera.com/join-our-team](https://www.kailera.com/join-our-team/)
- **Work Model**: Hybrid and remote options available – many roles are based in Waltham, MA, but some (e.g., Statistical Programming, Clinical Quality Assurance) are listed as US‑Remote.
- **Notable Perks**: Purpose‑driven work in a fast‑growing therapeutic area; opportunity to work with top industry veterans; exposure to a pipeline that spans multiple cutting‑edge modalities (injectable, oral, small molecule).
- **Growth Opportunity**: With 29 open positions across all levels (Associate Director to Senior Director), the company is scaling rapidly, offering significant career advancement in a high‑impact field.

## Sources
1. [kailera.com](https://www.kailera.com/)
2. [kailera.com/about-us](https://www.kailera.com/about-us/)
3. [kailera.com/leadership](https://www.kailera.com/leadership/)
4. [kailera.com/join-our-team](https://www.kailera.com/join-our-team/)
5. [job-boards.greenhouse.io/kailera](http://job-boards.greenhouse.io/kailera)

## Other roles at Kailera Therapeutics, Inc.

- [Associate Director, Clinical Scientist](https://feeny.ai/job/associate-director-clinical-scientist-kailera-therapeutics-inc-waltham-sgrctnmfaxpv) — Waltham, MA
- [Associate Director, Program Management (Early Pipeline)](https://feeny.ai/job/associate-director-program-management-early-pipeline-kailera-therapeutics-inc-d3xve0y35etn) — Waltham, MA
- [Senior Director, Drug Substance Commercial Manufacturing](https://feeny.ai/job/senior-director-drug-substance-commercial-manufacturing-kailera-therapeutics-wxj0jjh230fc) — United States
- [Director, Drug Substance Commercial Manufacturing](https://feeny.ai/job/director-drug-substance-commercial-manufacturing-kailera-therapeutics-inc-dmr3vs8w638q) — United States
- [Manager, Patient Retention](https://feeny.ai/job/manager-patient-retention-kailera-therapeutics-inc-waltham-tewqr6aad1a2) — Waltham, MA
- [Director, Analytical Development and Quality Control](https://feeny.ai/job/director-analytical-development-and-quality-control-kailera-therapeutics-inc-dcvdqtvsxt3e) — United States
- [Associate Director, CMC Operations](https://feeny.ai/job/associate-director-cmc-operations-kailera-therapeutics-inc-united-states-39cdrzcbwtbm) — United States
- [Vice President, CMC Regulatory Affairs](https://feeny.ai/job/vice-president-cmc-regulatory-affairs-kailera-therapeutics-inc-united-states-t441rhykr9wc) — United States
- [Vice President, Global Supply Chain](https://feeny.ai/job/vice-president-global-supply-chain-kailera-therapeutics-inc-united-states-1z9qjwy9fyqy) — United States
- [Vice President, CMC Development and Drug Delivery Innovation](https://feeny.ai/job/vice-president-cmc-development-and-drug-delivery-innovation-kailera-egdk13skt2za) — United States